EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success

Uwe Grether iD

Pharmaceuticals · 04.09.2025 · 18 (9) · 1324

DOI: 10.3390/ph18091324 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 04.09.2025. Verfasst von Uwe Grether. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Special Issue of Pharmaceuticals presents eight original articles and three reviews, underscoring the ongoing robust interest in research on cannabinoid receptor type 1 (CB1R) and type 2 (CB2R) more than 30 years after their discovery [...]

Autor:innen und Institutionen

  • Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.

ORCID-Profile: Uwe Grether

Zitieren

APA

Grether, U. (2025). Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success. Pharmaceuticals, 18(9), 1324. https://doi.org/10.3390/ph18091324

Vancouver

Grether U. Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success. Pharmaceuticals. 2025;18(9):1324. doi:10.3390/ph18091324

BibTeX
@article{Grether2025,
  author = {Grether, Uwe},
  title = {Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {9},
  pages = {1324},
  doi = {10.3390/ph18091324}
}
Kostenlos starten →